Eris Lifesciences Limited has informed the Exchange about Schedule of meet
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences Limited has submitted a filing to the National Stock Exchange informing about a scheduled meeting. The exact agenda, date, and nature of the meeting (board meeting, analyst meet, or investor call) are not specified in the headline. Such filings are routine regulatory disclosures required under SEBI listing norms whenever a company schedules a board or investor interaction. Retail investors should watch for the follow-up filing or outcome of this meeting for any material announcements, including financial results, approvals, or strategic decisions.
This is a routine procedural disclosure with no immediate impact on shareholders. Any material development from the meeting would come through a separate filing, which could influence stock price depending on the outcome.